To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene ALKBH3TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
262 supporting clones for gene ALKBH3 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BX501306 Liver ALKBH3.a 1 to 636 1 to 636       636/694
(91 %)
3 diff
(99.6 %id)
BP256644 Kidney ALKBH3.a 1 to 574 1 to 574   tiling clone,   574/574
(100 %)
1 diff
(99.9 %id)
BP256669 Kidney ALKBH3.a 1 to 585 1 to 585       585/585
(100 %)
1 diff
(99.9 %id)
DA378626 thalamus ALKBH3.a 3 to 569 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
DB058999 testis ALKBH3.a 3 to 528 2 to 527   capped   526/526
(100 %)
1 diff
(99.9 %id)
DA750402   ALKBH3.a 7 to 571 2 to 566   capped   565/565
(100 %)
1 diff
(99.9 %id)
DA723980   ALKBH3.a 9 to 578 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
DA869280 Prostate ALKBH3.a 9 to 564 2 to 555   capped   554/554
(100 %)
1 diff
(99.9 %id)
BF346939 anaplastic oligodendroglioma with 1p/19qloss, brain ALKBH3.a 16 to 766 35 to 783       747/932
(80 %)
26 diff
(97.3 %id)
BG248481 adenocarcinoma cell line, colon ALKBH3.a 18 to 735 1 to 717       717/717
(100 %)
10 diff
(98.7 %id)
DA045533 bladder ALKBH3.a 21 to 604 2 to 585   capped   584/584
(100 %)
0 diff
(100 %id)
BI117225 lung, small cell carcinoma ALKBH3.a 21 to 730 1 to 707       707/865
(81 %)
30 diff
(96.6 %id)
BU856422 ovary, teratocarcinoma, cell line ALKBH3.a 21 to 766 1 to 751       751/898
(83 %)
11 diff
(98.8 %id)
DA615050   ALKBH3.a 21 to 571 2 to 554   capped   553/553
(100 %)
3 diff
(99.5 %id)
DA202570 brain ALKBH3.a 23 to 613 2 to 592   capped   591/591
(100 %)
1 diff
(99.9 %id)
DA667672 esophagus ALKBH3.a 23 to 587 2 to 566   capped   565/565
(100 %)
1 diff
(99.9 %id)
CF146984 CNCAP(3)T-225 cell line, Prostate ALKBH3.a 24 to 693 1 to 669   tiling clone,   669/669
(100 %)
5 diff
(99.3 %id)
CF147032 CNCAP(3)T-225 cell line, Prostate ALKBH3.a 24 to 523 1 to 500       500/500
(100 %)
25 diff
(95.0 %id)
CF147379 CNCAP(3)T-225 cell line, Prostate ALKBH3.a 24 to 612 1 to 589       589/590
(99 %)
5 diff
(99.2 %id)
CX872660 embryonic stem ALKBH3.a 26 to 815 1 to 790       790/790
(100 %)
2 diff
(99.8 %id)
TI_154179532   ALKBH3.a 29 to 821 74 to 858       785/857
(91 %)
14 diff
(98.4 %id)
TI_154179591   ALKBH3.a 29 to 612 70 to 653       584/843
(69 %)
30 diff
(96.5 %id)
TI_154180005   ALKBH3.a 32 to 743 69 to 773       705/878
(80 %)
18 diff
(98.0 %id)
BQ267637 insulinoma, Pancreas ALKBH3.a 38 to 594 8 to 564       557/564
(98 %)
6 diff
(99.0 %id)
DA692608   ALKBH3.a 66 to 605 2 to 542   capped   541/541
(100 %)
1 diff
(99.9 %id)
DB048627 testis ALKBH3.a 258 to 842 2 to 586   tiling clone, capped   585/585
(100 %)
0 diff
(100 %id)
BP288625 lung ALKBH3.a 283 to 867 1 to 584       584/584
(100 %)
3 diff
(99.5 %id)
BP286095 lung ALKBH3.a 284 to 865 1 to 581       581/581
(100 %)
5 diff
(99.2 %id)
BF933573 nervous_tumor ALKBH3.a 576 to 928 1 to 352   tiling clone,   352/352
(100 %)
8 diff
(97.8 %id)
BQ272207 insulinoma, Pancreas ALKBH3.a 933 to 1440 508 to 1   tiling clone,   508/508
(100 %)
3 diff
(99.5 %id)
DB329814 Prostate ALKBH3.a 1252 to 1806 556 to 2   tiling clone,   555/556
(99 %)
1 diff
(99.9 %id)
NM_139178.3   ALKBH3.b 1 to 1564 6 to 1569 exact RefSeq, AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 1569/1569
(100 %)
1 diff
(100.0 %id)
DA685031   ALKBH3.b 1 to 531 6 to 537   capped   536/537
(99 %)
3 diff
(99.5 %id)
DB031171 testis ALKBH3.b 1 to 586 3 to 589   capped   588/588
(100 %)
1 diff
(99.9 %id)
DB046483 testis ALKBH3.b 1 to 569 2 to 570   tiling clone, capped   569/569
(100 %)
0 diff
(100 %id)
BI222582 cervical carcinoma cell line, cervix ALKBH3.b 15 to 722 1 to 709       709/709
(100 %)
4 diff
(99.5 %id)
BI561482 testis ALKBH3.b 15 to 673 1 to 658       658/658
(100 %)
6 diff
(99.1 %id)
BX476038   ALKBH3.b 20 to 324 1 to 300       300/300
(100 %)
12 diff
(96.0 %id)
TI_44350701   ALKBH3.b 20 to 673 83 to 735       653/735
(88 %)
6 diff
(99.2 %id)
BP318094 pericardium ALKBH3.b 20 to 602 1 to 583       583/583
(100 %)
0 diff
(100 %id)
BP338897 Spleen ALKBH3.b 20 to 600 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
BP338899 Spleen ALKBH3.b 20 to 599 1 to 580       580/580
(100 %)
0 diff
(100 %id)
BP340582 Spleen ALKBH3.b 20 to 601 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BP353415   ALKBH3.b 20 to 599 1 to 580       580/582
(99 %)
1 diff
(99.9 %id)
DA109186 cerebellum ALKBH3.b 21 to 599 2 to 580   capped   579/579
(100 %)
0 diff
(100 %id)
DA329962 hippocampus ALKBH3.b 21 to 539 2 to 520   capped   519/519
(100 %)
0 diff
(100 %id)
CD388633 embryonic trophoblasts, made from WA01 stemcells ALKBH3.b 21 to 840 21 to 839       819/877
(93 %)
13 diff
(98.6 %id)
DB094165 testis ALKBH3.b 21 to 564 2 to 545   capped   544/544
(100 %)
0 diff
(100 %id)
DB276882 uterus ALKBH3.b 21 to 572 2 to 554   capped   553/553
(100 %)
1 diff
(99.9 %id)
DB504857 hypothalamus ALKBH3.b 22 to 482 1 to 462       462/462
(100 %)
1 diff
(99.8 %id)
AI815484 brain, frontal lobe ALKBH3.b 23 to 478 29 to 484       456/484
(94 %)
6 diff
(98.8 %id)
DB455669 testis ALKBH3.b 24 to 502 1 to 479       479/479
(100 %)
0 diff
(100 %id)
BP194657 brain ALKBH3.b 26 to 607 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
DA141338 alzheimer cortex ALKBH3.b 27 to 593 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
DB033777 testis ALKBH3.b 27 to 612 2 to 587   capped   586/588
(99 %)
1 diff
(99.9 %id)
DB294561   ALKBH3.b 27 to 885 2 to 856   capped   855/855
(100 %)
8 diff
(99.1 %id)
CR615997 Placenta Cot 25-normalized ALKBH3.b 28 to 1501 1 to 1474 exact     1474/1474
(100 %)
0 diff
(100 %id)
BI918447 brain ALKBH3.b 32 to 894 1 to 868       868/966
(89 %)
14 diff
(98.6 %id)
TI_57238309   ALKBH3.b 32 to 894 1 to 868       868/966
(89 %)
14 diff
(98.6 %id)
AB042029   ALKBH3.b 33 to 1552 1 to 1520 exact     1520/1520
(100 %)
3 diff
(99.9 %id)
BX361668   ALKBH3.b 34 to 811 1 to 777       709/777
(91 %)
17 diff
(97.9 %id)
BM545966 ovary (pool of 3) ALKBH3.b 35 to 1106 21 to 1102       1082/1126
(96 %)
41 diff
(96.4 %id)
CD672147 eye, Iris ALKBH3.b 37 to 687 1 to 651       651/651
(100 %)
0 diff
(100 %id)
BP249003 Kidney ALKBH3.b 37 to 617 1 to 582       582/582
(100 %)
3 diff
(99.5 %id)
CD636776   ALKBH3.b 38 to 569 8 to 540       533/540
(98 %)
9 diff
(98.4 %id)
CN392861 embryonic stem cells, DMSO-treated H9 cellline ALKBH3.b 38 to 754 1 to 717       717/717
(100 %)
1 diff
(99.9 %id)
BG831972 epithelioid carcinoma cell line, Pancreas ALKBH3.b 38 to 705 1 to 673       673/835
(80 %)
18 diff
(97.9 %id)
BQ233246 epithelioid carcinoma, Pancreas ALKBH3.b 38 to 809 1 to 773       773/876
(88 %)
6 diff
(99.4 %id)
BX406645 fetal liver, Liver ALKBH3.b 39 to 887 1 to 848       848/858
(98 %)
11 diff
(98.8 %id)
BM561898 blood, natural killer cells, cell line ALKBH3.b 39 to 1026 14 to 1009       996/1068
(93 %)
32 diff
(97.1 %id)
BM917712 blood, natural killer cells, cell line ALKBH3.b 39 to 809 9 to 778       770/1055
(72 %)
18 diff
(98.3 %id)
DA608502   ALKBH3.b 39 to 583 2 to 546   capped   545/545
(100 %)
0 diff
(100 %id)
BP193281 brain ALKBH3.b 40 to 620 1 to 582       582/582
(100 %)
3 diff
(99.5 %id)
CR612017 Placenta Cot 25-normalized ALKBH3.b 41 to 1524 1 to 1484 exact     1484/1484
(100 %)
0 diff
(100 %id)
AL543545 placenta, Placenta Cot 25-normalized ALKBH3.b 41 to 928 1 to 888   fully sequenced,   888/888
(100 %)
2 diff
(99.8 %id)
CR621454 Placenta Cot 25-normalized ALKBH3.b 44 to 1505 1 to 1462 exact     1462/1462
(100 %)
0 diff
(100 %id)
CR623815 Placenta Cot 25-normalized ALKBH3.b 44 to 1525 1 to 1482 exact tiling clone,   1482/1482
(100 %)
0 diff
(100 %id)
AL546752 placenta, Placenta Cot 25-normalized ALKBH3.b 44 to 735 1 to 691   fully sequenced,   691/691
(100 %)
2 diff
(99.8 %id)
AL551979 placenta, Placenta Cot 25-normalized ALKBH3.b 44 to 839 1 to 796   fully sequenced,   796/796
(100 %)
1 diff
(99.9 %id)
BG772137 testis ALKBH3.b 47 to 895 1 to 848       848/933
(90 %)
23 diff
(97.6 %id)
BI823026 pooled brain, lung, testis ALKBH3.b 50 to 843 1 to 794       794/797
(99 %)
11 diff
(98.7 %id)
TI_57201582   ALKBH3.b 50 to 843 32 to 825       794/828
(95 %)
16 diff
(98.1 %id)
BQ939674 eye, normal pigmented retinal epithelium ALKBH3.b 51 to 905 1 to 863       863/939
(91 %)
19 diff
(98.0 %id)
AW247495 lung, small cell carcinoma ALKBH3.b 53 to 593 9 to 550       542/550
(98 %)
6 diff
(99.0 %id)
BE791860 lung, small cell carcinoma ALKBH3.b 53 to 793 1 to 744       744/1147
(64 %)
19 diff
(98.4 %id)
AL554302 placenta, Placenta Cot 25-normalized ALKBH3.b 54 to 839 26 to 812   fully sequenced,   787/812
(96 %)
9 diff
(98.9 %id)
BE408144 choriocarcinoma, placenta ALKBH3.b 55 to 845 1 to 793       793/794
(99 %)
8 diff
(99.0 %id)
BM011189 brain, neuroblastoma, cell line ALKBH3.b 55 to 720 1 to 666       666/666
(100 %)
1 diff
(99.9 %id)
BE274419 melanotic melanoma, skin ALKBH3.b 56 to 897 1 to 840       840/905
(92 %)
24 diff
(97.4 %id)
BE887345 leiomyosarcoma, uterus ALKBH3.b 56 to 785 1 to 720       720/878
(82 %)
19 diff
(97.9 %id)
TI_59380344   ALKBH3.b 56 to 720 60 to 724       665/665
(100 %)
0 diff
(100 %id)
BF026256 melanotic melanoma, skin ALKBH3.b 57 to 808 1 to 735       735/834
(88 %)
21 diff
(97.5 %id)
BU179848 melanotic melanoma, cell line, skin ALKBH3.b 57 to 811 24 to 779       756/990
(76 %)
15 diff
(98.5 %id)
CD243877 testis ALKBH3.b 59 to 605 23 to 570       548/998
(54 %)
9 diff
(99.1 %id)
BU553708 ovary, teratocarcinoma, cell line ALKBH3.b 61 to 894 1 to 839       839/934
(89 %)
21 diff
(97.8 %id)
DR158045 human embryonic stem cells differentiated toan early endodermal cell type ALKBH3.b 61 to 781 1 to 721       721/721
(100 %)
1 diff
(99.9 %id)
BE260229 brain, neuroblastoma ALKBH3.b 64 to 696 1 to 632       632/681
(92 %)
7 diff
(99.0 %id)
BE269759 Burkitt lymphoma, lymph ALKBH3.b 64 to 582 1 to 519       519/519
(100 %)
0 diff
(100 %id)
CX755489 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass ALKBH3.b 64 to 810 1 to 739       739/849
(87 %)
13 diff
(98.5 %id)
BE296263 muscle, rhabdomyosarcoma ALKBH3.b 65 to 568 1 to 504       504/504
(100 %)
0 diff
(100 %id)
BE296128 muscle, rhabdomyosarcoma ALKBH3.b 65 to 656 1 to 591       591/591
(100 %)
1 diff
(99.9 %id)
BE792222 lung, small cell carcinoma ALKBH3.b 70 to 787 17 to 732       716/732
(97 %)
9 diff
(98.8 %id)
BI919236 brain ALKBH3.b 73 to 652 75 to 672       598/672
(88 %)
25 diff
(96.3 %id)
TI_57242242   ALKBH3.b 73 to 652 75 to 672       598/672
(88 %)
25 diff
(96.3 %id)
DR159568 human embryonic stem cells differentiated toan early endodermal cell type ALKBH3.b 77 to 772 1 to 696       696/696
(100 %)
1 diff
(99.9 %id)
DN996780 breast cancer, Mammary gland (cancer tissue) ALKBH3.b 92 to 722 1 to 631       631/631
(100 %)
2 diff
(99.7 %id)
AA172364   ALKBH3.b 106 to 516 1 to 421       421/422
(99 %)
20 diff
(95.3 %id)
DR761449 embryonic stem ALKBH3.b 129 to 772 1 to 644       644/644
(100 %)
5 diff
(99.3 %id)
BP430560   ALKBH3.b 129 to 353 1 to 225       225/225
(100 %)
6 diff
(97.4 %id)
CD636775   ALKBH3.b 157 to 911 764 to 10       755/764
(98 %)
1 diff
(99.9 %id)
AA187097   ALKBH3.b 225 to 588 1 to 371       371/373
(99 %)
14 diff
(96.3 %id)
BP234145 coronary artery ALKBH3.b 248 to 839 1 to 592       592/592
(100 %)
11 diff
(98.2 %id)
BC103812 PCR rescued clones ALKBH3.b 258 to 1415 1 to 1158 D228E     1158/1158
(100 %)
2 diff
(99.9 %id)
BC103813 PCR rescued clones ALKBH3.b 258 to 1415 1 to 1158 exact     1158/1158
(100 %)
2 diff
(99.9 %id)
BC103814 PCR rescued clones ALKBH3.b 258 to 1418 1 to 1161 exact     1161/1161
(100 %)
2 diff
(99.9 %id)
DA939395 Spleen ALKBH3.b 279 to 872 2 to 595   capped   594/594
(100 %)
1 diff
(99.9 %id)
BG282971 adenocarcinoma, cell line, Prostate ALKBH3.b 322 to 1107 1 to 800       800/1023
(78 %)
10 diff
(99.1 %id)
BG283085 adenocarcinoma, cell line, Prostate ALKBH3.b 415 to 1192 1 to 776       776/1050
(73 %)
27 diff
(97.5 %id)
BF724816 eye, Iris ALKBH3.b 418 to 1032 1 to 615       615/615
(100 %)
1 diff
(99.9 %id)
FN137693 breast carcinoma ALKBH3.b 510 to 594 1 to 83       83/83
(100 %)
7 diff
(91.6 %id)
CN392860 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells ALKBH3.b 515 to 1096 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
CB144545 Liver ALKBH3.b 537 to 671 1 to 135       135/135
(100 %)
1 diff
(99.3 %id)
BX406644 fetal liver, Liver ALKBH3.b 551 to 1512 961 to 1       961/961
(100 %)
9 diff
(99.1 %id)
BE250119 adenocarcinoma cell line, colon ALKBH3.b 553 to 1336 31 to 812       782/986
(79 %)
28 diff
(97.2 %id)
BE293567 adenocarcinoma cell line, colon ALKBH3.b 573 to 1151 1 to 580       580/580
(100 %)
3 diff
(99.5 %id)
BE293665 adenocarcinoma cell line, colon ALKBH3.b 573 to 1105 1 to 533       533/533
(100 %)
1 diff
(99.9 %id)
BI860137 breast, mammary adenocarcinoma, cell line ALKBH3.b 574 to 1388 1 to 817       817/818
(99 %)
7 diff
(99.2 %id)
TI_57189963   ALKBH3.b 574 to 1388 56 to 872       817/818
(99 %)
7 diff
(99.2 %id)
BE249876 adenocarcinoma cell line, colon ALKBH3.b 575 to 1418 1 to 841       841/904
(93 %)
29 diff
(96.8 %id)
BF823012 kidney_tumor ALKBH3.b 593 to 797 1 to 205       205/205
(100 %)
2 diff
(99.1 %id)
TI_149294593   ALKBH3.b 660 to 1555 981 to 86   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 896/1001
(89 %)
14 diff
(98.7 %id)
TI_149303127   ALKBH3.b 660 to 1557 976 to 86   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 891/960
(92 %)
22 diff
(97.8 %id)
TI_227716978   ALKBH3.b 660 to 1564 986 to 97   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 890/1008
(88 %)
21 diff
(98.0 %id)
AL571973 placenta, Placenta Cot 25-normalized ALKBH3.b 674 to 1505 832 to 1   fully sequenced,   832/832
(100 %)
9 diff
(99.0 %id)
AA169457   ALKBH3.b 695 to 1184 1 to 490       490/497
(98 %)
9 diff
(98.2 %id)
CU448228 epidermis ALKBH3.b 703 to 953 266 to 16     Submitted on the opposite strand 251/273
(91 %)
4 diff
(98.6 %id)
BC015155 Lung, large cell carcinoma ALKBH3.b 710 to 1562 1 to 853   available from MGC, AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 853/853
(100 %)
2 diff
(99.8 %id)
BM824362 Ascites, stomach ALKBH3.b 722 to 1303 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
BM792655 Ascites, stomach ALKBH3.b 724 to 1399 1 to 676       676/676
(100 %)
3 diff
(99.6 %id)
TI_227714611   ALKBH3.b 729 to 1555 929 to 111   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 819/962
(85 %)
16 diff
(98.4 %id)
BE789024 large cell carcinoma, lung ALKBH3.b 730 to 1527 1 to 800   available from MGC,   800/802
(99 %)
33 diff
(95.9 %id)
AL551946 placenta, Placenta Cot 25-normalized ALKBH3.b 778 to 1523 749 to 3   fully sequenced,   747/749
(99 %)
5 diff
(99.4 %id)
AL577048 placenta, Placenta Cot 25-normalized ALKBH3.b 778 to 1490 724 to 12   fully sequenced,   713/724
(98 %)
16 diff
(97.8 %id)
TI_154101718   ALKBH3.b 807 to 1556 832 to 85   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 748/766
(97 %)
14 diff
(98.2 %id)
BX390609   ALKBH3.b 811 to 1561 1 to 751       751/751
(100 %)
3 diff
(99.7 %id)
BM981193 lung, Primary Lung Cystic Fibrosis EpithelialCells ALKBH3.b 836 to 1557 740 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 722/722
(100 %)
5 diff
(99.4 %id)
AA172190   ALKBH3.b 843 to 1206 374 to 12       365/374
(97 %)
6 diff
(98.4 %id)
CD364334 Alveolar Macrophage, lung ALKBH3.b 864 to 1564 717 to 17   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 701/701
(100 %)
1 diff
(99.9 %id)
AL570007 placenta, Placenta Cot 25-normalized ALKBH3.b 867 to 1524 660 to 1   fully sequenced,   660/660
(100 %)
13 diff
(98.1 %id)
BM985113 lung ALKBH3.b 871 to 1555 703 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 685/685
(100 %)
2 diff
(99.8 %id)
BM999346 Fibrosarcoma ALKBH3.b 875 to 1562 707 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 689/689
(100 %)
3 diff
(99.6 %id)
CV029716 mixed ALKBH3.b 880 to 1047 1 to 168       168/168
(100 %)
3 diff
(98.3 %id)
TI_1948152677   ALKBH3.b 880 to 1298 128 to 546       419/627
(66 %)
8 diff
(98.8 %id)
CB048424 Prostate ALKBH3.b 886 to 1489 14 to 617       604/617
(97 %)
2 diff
(99.7 %id)
BM694348 eye, RPE and Choroid ALKBH3.b 887 to 1333 1 to 447       447/447
(100 %)
3 diff
(99.4 %id)
BM704858 eye, RPE and Choroid ALKBH3.b 887 to 1270 1 to 384       384/384
(100 %)
2 diff
(99.5 %id)
BF763881 colon_est ALKBH3.b 899 to 1049 25 to 175       151/197
(76 %)
6 diff
(97.0 %id)
CN392859 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 ALKBH3.b 899 to 1549 1 to 651       651/651
(100 %)
1 diff
(99.9 %id)
BU631845 cell lines, Chondrosarcoma ALKBH3.b 963 to 1562 618 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 600/600
(100 %)
2 diff
(99.7 %id)
BU730492 eye, RPE and Choroid ALKBH3.b 967 to 1555 609 to 21   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 589/589
(100 %)
2 diff
(99.7 %id)
CA445168 Chondrosarcoma, Left Pelvis ALKBH3.b 970 to 1556 605 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 587/587
(100 %)
2 diff
(99.7 %id)
BQ017150 lung, Metastatic Chondrosarcoma ALKBH3.b 971 to 1555 603 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 585/593
(98 %)
1 diff
(99.9 %id)
CD365271 Alveolar Macrophage, lung ALKBH3.b 971 to 1555 603 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 585/585
(100 %)
2 diff
(99.7 %id)
BM971930 lung ALKBH3.b 974 to 1555 600 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 582/584
(99 %)
1 diff
(99.9 %id)
BU788104 insulinoma, Pancreas ALKBH3.b 993 to 1278 1 to 286   fully sequenced,   286/286
(100 %)
4 diff
(98.7 %id)
BQ181579 Knee, Osteoarthritic Cartilage ALKBH3.b 995 to 1555 580 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 562/562
(100 %)
6 diff
(99.0 %id)
BF062547 colon, colon tumor, RER+ ALKBH3.b 1006 to 1555 554 to 5       550/554
(99 %)
2 diff
(99.7 %id)
DB384699   ALKBH3.b 1007 to 1562 556 to 1       556/556
(100 %)
11 diff
(98.1 %id)
AI636076 Kidney ALKBH3.b 1038 to 1555 518 to 1       518/518
(100 %)
3 diff
(99.5 %id)
DB576117 hypothalamus ALKBH3.b 1067 to 1555 1 to 489     Submitted on the opposite strand 489/490
(99 %)
4 diff
(99.2 %id)
BE937862 testis_normal ALKBH3.b 1080 to 1557 11 to 489       479/498
(96 %)
19 diff
(96.2 %id)
BQ375279 testis_normal ALKBH3.b 1080 to 1538 1 to 457       457/457
(100 %)
4 diff
(99.2 %id)
BF886167 testis_normal ALKBH3.b 1084 to 1545 468 to 6     Submitted on the opposite strand 463/468
(98 %)
1 diff
(99.8 %id)
BQ375282 testis_normal ALKBH3.b 1084 to 1539 460 to 6       455/460
(98 %)
1 diff
(99.8 %id)
BQ375283 testis_normal ALKBH3.b 1086 to 1468 440 to 66       375/440
(85 %)
3 diff
(99.4 %id)
BG187465   ALKBH3.b 1105 to 1562 1 to 459   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 459/459
(100 %)
7 diff
(98.5 %id)
BG191648   ALKBH3.b 1105 to 1555 1 to 450   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 450/450
(100 %)
8 diff
(98.3 %id)
AI656885 pooled germ cell tumors ALKBH3.b 1107 to 1558 468 to 17   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 452/474
(95 %)
1 diff
(99.8 %id)
AI916587 Kidney ALKBH3.b 1107 to 1555 450 to 2       449/471
(95 %)
1 diff
(99.8 %id)
BG370227 adenocarcinoma, Pancreas ALKBH3.b 1108 to 1555 453 to 6       448/490
(91 %)
5 diff
(99.0 %id)
BI833740 pooled pancreas and spleen ALKBH3.b 1108 to 1619 18 to 526   tiling clone,   509/778
(65 %)
13 diff
(98.4 %id)
TI_57166829   ALKBH3.b 1108 to 1619 47 to 555       509/807
(63 %)
9 diff
(98.9 %id)
DB521107 testis ALKBH3.b 1118 to 1549 1 to 432     Submitted on the opposite strand 432/434
(99 %)
3 diff
(99.4 %id)
BG188518   ALKBH3.b 1123 to 1563 20 to 459       440/462
(95 %)
9 diff
(98.1 %id)
AW001947 thymus, pooled ALKBH3.b 1123 to 1563 448 to 8       441/448
(98 %)
1 diff
(99.8 %id)
AA932508 carcinoid, lung ALKBH3.b 1133 to 1555 424 to 2       423/424
(99 %)
1 diff
(99.8 %id)
AW860831 colon ALKBH3.b 1138 to 1296 1 to 158       158/166
(95 %)
5 diff
(97.0 %id)
AI370748 uterus ALKBH3.b 1138 to 1555 425 to 8       418/425
(98 %)
1 diff
(99.8 %id)
AW451472   ALKBH3.b 1138 to 1555 435 to 18   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 418/425
(98 %)
2 diff
(99.6 %id)
BM675933 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid ALKBH3.b 1143 to 1561 437 to 19   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 419/427
(98 %)
1 diff
(99.8 %id)
TI_151775025   ALKBH3.b 1143 to 1562 86 to 504       419/1016
(41 %)
3 diff
(99.8 %id)
AA187306   ALKBH3.b 1159 to 1561 403 to 1       403/403
(100 %)
1 diff
(99.8 %id)
AW135325   ALKBH3.b 1169 to 1556 405 to 18   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 388/388
(100 %)
0 diff
(100 %id)
AI572836 Kidney ALKBH3.b 1174 to 1456 293 to 11   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 283/283
(100 %)
0 diff
(100 %id)
AW804009 uterus ALKBH3.b 1176 to 1526 31 to 381       351/384
(91 %)
14 diff
(96.4 %id)
BU784435 insulinoma, Pancreas ALKBH3.b 1176 to 1251 76 to 1   fully sequenced,   76/76
(100 %)
0 diff
(100 %id)
AI203279 pooled germ cell tumors ALKBH3.b 1205 to 1555 358 to 8       351/358
(98 %)
0 diff
(100 %id)
AI700490 carcinoid, lung ALKBH3.b 1223 to 1555 333 to 1       333/333
(100 %)
0 diff
(100 %id)
CV428289 head_neck ALKBH3.b 1237 to 1518 282 to 1     Submitted on the opposite strand 282/282
(100 %)
17 diff
(94.0 %id)
AI582386 adenocarcinoma, Pancreas ALKBH3.b 1238 to 1555 334 to 18   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 317/317
(100 %)
5 diff
(98.5 %id)
AI766549 colon, colon tumor, RER+ ALKBH3.b 1256 to 1563 316 to 9       308/316
(97 %)
0 diff
(100 %id)
AA569865 breast ALKBH3.b 1285 to 1562 300 to 23   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 278/278
(100 %)
0 diff
(100 %id)
EC533097 Prostate ALKBH3.b 1293 to 1385 1 to 101       101/101
(100 %)
5 diff
(95.1 %id)
EC547525 Prostate ALKBH3.b 1293 to 1385 1 to 101       101/101
(100 %)
7 diff
(93.1 %id)
FN050958 breast carcinoma ALKBH3.b 1301 to 1391 1 to 91       91/91
(100 %)
1 diff
(99.0 %id)
AI971018 cochlea, ear, Prostate ALKBH3.b 1319 to 1450 132 to 1       132/132
(100 %)
2 diff
(98.5 %id)
U38442   ALKBH3.b 1382 to 1553 1 to 172       172/174
(98 %)
1 diff
(99.5 %id)
AA989187 Kidney, kidney tumor ALKBH3.b 1383 to 1561 203 to 25   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 179/179
(100 %)
2 diff
(98.9 %id)
BF115453 fibrotheoma, ovary ALKBH3.b 1391 to 1555 175 to 11   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 165/165
(100 %)
2 diff
(98.8 %id)
BU590014 mixed (pool of 40 RNAs) ALKBH3.b 1400 to 1562 1 to 163   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 163/163
(100 %)
2 diff
(98.8 %id)
CD512656 Pooled-Skin ALKBH3.b 1400 to 1556 1 to 157   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 157/159
(98 %)
3 diff
(98.2 %id)
AI307765 2 pooled tumors (clear cell type), Kidney ALKBH3.b 1502 to 1555 59 to 6       54/65
(83 %)
0 diff
(100 %id)
AW070233 pooled ALKBH3.c-u 1 to 597 598 to 1       598/598
(100 %)
2 diff
(99.7 %id)
NR_026952.1   ALKBH3.c-u 1 to 2570 1 to 2570 exact RefSeq, tiling clone, AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 2570/2570
(100 %)
0 diff
(100 %id)
AI091812 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus ALKBH3.c-u 147 to 598 452 to 1       452/452
(100 %)
1 diff
(99.8 %id)
AI354518 follicular lymphoma, lymph node ALKBH3.c-u 154 to 597 444 to 1       444/444
(100 %)
2 diff
(99.6 %id)
AW770752 carcinoid, lung ALKBH3.c-u 161 to 604 451 to 4   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 448/451
(99 %)
0 diff
(100 %id)
AW375729 colon ALKBH3.c-u 172 to 404 10 to 246       237/246
(96 %)
6 diff
(97.6 %id)
BF037645 adenocarcinoma, ovary ALKBH3.d 1 to 772 1 to 773 L91C Y92I P93L G94A F95C ... tiling clone,   773/799
(96 %)
27 diff
(96.7 %id)
CR602476 fetal liver ALKBH3.e 1 to 1468 3 to 1470 exact tiling clone,   1470/1470
(100 %)
0 diff
(100 %id)
AA148993 colon, tumor ALKBH3.e 6 to 402 1 to 403       403/403
(100 %)
11 diff
(97.3 %id)
AA148994 colon, tumor ALKBH3.e 1161 to 1517 362 to 3   tiling clone,   360/393
(91 %)
0 diff
(100 %id)
AK315266 testis ALKBH3.f 1 to 1370 2 to 1371 exact tiling clone,   1371/1371
(100 %)
2 diff
(99.9 %id)
BM728218 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid ALKBH3.f 40 to 535 1 to 495     Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 495/495
(100 %)
4 diff
(99.2 %id)
BM681387 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid ALKBH3.f 1031 to 1626 613 to 18   tiling clone, AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 596/596
(100 %)
3 diff
(99.5 %id)
BC067257 Peripheral Nervous System, dorsal rootganglion ALKBH3.g 1 to 1557 1 to 1557 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 1557/1557
(100 %)
2 diff
(99.9 %id)
BU838356 dorsal root ganglia ALKBH3.g 2 to 891 1 to 908 T129N F130L K131*     908/968
(93 %)
18 diff
(98.2 %id)
BE891036 melanotic melanoma, skin ALKBH3.g 17 to 694 1 to 677       677/677
(100 %)
1 diff
(99.9 %id)
DA866814 Prostate ALKBH3.g 184 to 729 2 to 547   tiling clone, capped   546/547
(99 %)
2 diff
(99.7 %id)
TI_1948237045   ALKBH3.g 371 to 896 136 to 661 G158C W168R     526/659
(79 %)
15 diff
(97.8 %id)
TI_1948237046   ALKBH3.g 376 to 896 134 to 656 C90M L91F Y92V P93S G94*     523/1429
(36 %)
34 diff
(97.7 %id)
EL737015 mixed ALKBH3.g 377 to 896 1 to 520 exact     520/628
(82 %)
6 diff
(99.1 %id)
TI_1948236688   ALKBH3.g 447 to 896 1049 to 599     Submitted on the opposite strand 451/1275
(35 %)
17 diff
(98.7 %id)
BG823846 adenocarcinoma cell line, colon ALKBH3.h 1 to 605 8 to 632   tiling clone,   632/662
(95 %)
23 diff
(96.6 %id)
BE892721 melanotic melanoma, skin ALKBH3.h 465 to 1112 1 to 646   tiling clone,   646/646
(100 %)
11 diff
(98.3 %id)
TI_149286322   ALKBH3.i 1 to 899 1007 to 100 F2S P3G G4W N5S R6L ... tiling clone, AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 908/1231
(73 %)
48 diff
(96.2 %id)
BM548608 brain, hippocampus ALKBH3.j 1 to 974 12 to 988 W115L K116E Q117T R118E T119D ... tiling clone,   977/1057
(92 %)
19 diff
(98.3 %id)
BI917188 brain ALKBH3.j 3 to 813 1 to 863 E3D K4E R5D R6G R7E ...     719/863
(83 %)
117 diff
(86.5 %id)
TI_57242249   ALKBH3.j 3 to 813 35 to 897 E2M K4E R5D R6E R7D ...     777/897
(86 %)
100 diff
(88.9 %id)
BI258292 cervical carcinoma cell line, cervix ALKBH3.j 397 to 1251 4 to 862 E2W G12A tiling clone,   859/867
(99 %)
19 diff
(97.9 %id)
TI_154103259   ALKBH3.j 578 to 1426 949 to 101   AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 849/990
(85 %)
8 diff
(99.2 %id)
CK724934 Chondrosarcoma, Left Pubic Bone ALKBH3.j 702 to 1426 743 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 725/725
(100 %)
3 diff
(99.6 %id)
BU602469 mixed (pool of 40 RNAs) ALKBH3.j 715 to 1420 1 to 712   tiling clone,   712/734
(97 %)
14 diff
(98.1 %id)
DA708027   ALKBH3.k 1 to 545 2 to 546 L49P tiling clone, capped   545/546
(99 %)
3 diff
(99.5 %id)
H81964.
matches multiple genes
melanocyte ALKBH3.k 359 to 731 411 to 2   tiling clone, also hits gene C17orf86andSCARNA16andSEC14L1 410/411
(99 %)
0 diff
(100 %id)
BQ707949 Spleen ALKBH3.k 814 to 1709 1 to 904   tiling clone,   904/918
(98 %)
33 diff
(96.5 %id)
BG112955 Bone, osteosarcoma, cell line ALKBH3.k 833 to 1285 1 to 453       453/454
(99 %)
1 diff
(99.8 %id)
AV747063 Pituitary ALKBH3.k 833 to 1379 1 to 542       542/547
(99 %)
10 diff
(98.2 %id)
CX755502 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass ALKBH3.k 1026 to 1775 1 to 743   tiling clone, Submitted on the opposite strand 743/831
(89 %)
11 diff
(98.7 %id)
R94162 liver and spleen ALKBH3.k 1666 to 1974 1 to 309   tiling clone,   309/313
(98 %)
1 diff
(99.7 %id)
BX099212 ovary ALKBH3.k 1897 to 2354 14 to 471   tiling clone,   458/471
(97 %)
6 diff
(98.8 %id)
AV763865 bone marrow ALKBH3.k 2142 to 2560 49 to 465       417/465
(89 %)
6 diff
(98.8 %id)
AV761014 bone marrow ALKBH3.k 2155 to 2714 1 to 560   tiling clone, AAA Possibly primed on the genome, locally A rich (17/18 A in genome downstream of last aligned base) 560/561
(99 %)
2 diff
(99.7 %id)
AW882316 ovary ALKBH3.k 2262 to 2710 453 to 5       449/460
(97 %)
0 diff
(100 %id)
AA847695 ovary ALKBH3.k 2298 to 2725 428 to 1       428/428
(100 %)
2 diff
(99.6 %id)
AW979308   ALKBH3.k 2364 to 2737 479 to 106     Submitted on the opposite strand 374/481
(77 %)
0 diff
(100 %id)
AA559282 Prostate, prostatic intraepithelial neoplasia - highgrade ALKBH3.k 2386 to 2733 356 to 9   tiling clone,   348/356
(97 %)
0 diff
(100 %id)
DA902954   ALKBH3.l 1 to 563 2 to 564 C5Y tiling clone, capped   563/563
(100 %)
1 diff
(99.9 %id)
DB010217 colon, tumor tissue ALKBH3.l 1 to 576 2 to 581 exact tiling clone, capped   580/580
(100 %)
5 diff
(99.2 %id)
DB107993 thymus ALKBH3.l 5 to 568 2 to 565 exact capped   564/564
(100 %)
0 diff
(100 %id)
AK125602 Spleen ALKBH3.m-u 1 to 2618 2 to 2619 exact tiling clone, available from FLJ,   2619/2619
(100 %)
7 diff
(99.8 %id)
DA941744 Spleen ALKBH3.m-u 1 to 490 2 to 495 L54F H55A capped   494/494
(100 %)
4 diff
(99.2 %id)
BE090552 breast ALKBH3.m-u 410 to 857 1 to 448   tiling clone,   448/448
(100 %)
9 diff
(98.0 %id)
DB333227 Spleen ALKBH3.m-u 2082 to 2618 537 to 1       537/537
(100 %)
1 diff
(99.9 %id)
BQ332301 lung_tumor ALKBH3.m-u 2152 to 2391 272 to 33       240/272
(88 %)
0 diff
(100 %id)
AA714942 Ewing's sarcoma ALKBH3.m-u 2183 to 2618 1 to 436       436/441
(98 %)
6 diff
(98.7 %id)
AI308216 2 pooled tumors (clear cell type), Kidney ALKBH3.m-u 2194 to 2618 430 to 6   tiling clone,   425/430
(98 %)
0 diff
(100 %id)
TI_57237345   ALKBH3.n 1 to 716 40 to 758 A30C K31*     719/982
(73 %)
17 diff
(98.3 %id)
BI908985 leukocyte ALKBH3.n 2 to 716 1 to 719 A30C K31* tiling clone,   719/943
(76 %)
13 diff
(98.7 %id)
BQ576341 Chondrosarcoma Grade II, Left Pelvis ALKBH3.o 1 to 682 700 to 19 D8X tiling clone, AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 682/682
(100 %)
4 diff
(99.5 %id)
BE304888 adenocarcinoma cell line, colon ALKBH3.p-u 1 to 666 693 to 10 L3V C7A H8M A9L E10Y ... tiling clone,   684/693
(98 %)
0 diff
(100 %id)
BE293758 adenocarcinoma cell line, colon ALKBH3.p-u 37 to 656 656 to 13   tiling clone,   644/832
(77 %)
0 diff
(100 %id)
BE305222 adenocarcinoma cell line, colon ALKBH3.p-u 122 to 661 578 to 4   tiling clone,   575/641
(89 %)
0 diff
(100 %id)
BE293474 adenocarcinoma cell line, colon Gene ALKBH3, variant not shown              
BG825625 muscle, rhabdomyosarcoma Gene ALKBH3, variant not shown         This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c-u, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m-u, .n, .o, .p-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes C